ArticleJournal of managed care & specialty pharmacy2023

Estimating long-term progression-free and overall survival in patients with peripheral T-cell lymphoma: A US population-based oncology simulation model based on 5-year results from the ECHELON-2 trial.

John M Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.